IL-22 also protected lung cancer cell lines from serum-starvation-induced and chemotherapeutic drug-induced apoptosis by activation of STAT3 and its downstream antiapoptotic proteins and inhibition extracellular signal-regulated kinase 1/2 [28]. Here, IL22 is linked to lung carcinoma.